<annotation text="Summary BACKGROUND: A case report about a patient with refractory uveitis-related cystoid macular edema (CME), that could be treated sucessfully with ranibizumab. MATERIAL AND METHODS: 0,5 mg intravitreal ranibizumab was injected monthly via pars plana, when needed. Need of injection was defined by CME in OCT. RESULTS: After 8 intravitreal injections of ranibizumab CME was resorbed and stayed without recurrence since 7 months. CONCLUSIONS: Ranibizumab has the potential to reduce uveitis-related CME and to improve vision.">
  <surfaceForm name="treated" offset="125">
    <resource label="Therapy" uri="Therapy" contextualScore="0.9974680392822418" percentageOfSecondRank="8.245557775315343E-4" support="1910" priorScore="1.58874224234215E-5" finalScore="0.9986039193394585" types=""/>
  </surfaceForm>
  <surfaceForm name="injection" offset="275">
    <resource label="Intramuscular injection" uri="Intramuscular_injection" contextualScore="0.9978150778393966" percentageOfSecondRank="0.0015374950898206844" support="219" priorScore="1.8216468642561826E-6" finalScore="0.9969849709366206" types=""/>
  </surfaceForm>
  <surfaceForm name="cystoid macular edema" offset="82">
    <resource label="Macular edema" uri="Macular_edema" contextualScore="1.0" percentageOfSecondRank="0.0" support="43" priorScore="3.576749550822642E-7" finalScore="1.0" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="CME" offset="300">
    <resource label="Continuing medical education" uri="Continuing_medical_education" contextualScore="0.981896288329898" percentageOfSecondRank="0.0027342720982225306" support="158" priorScore="1.3142475093720403E-6" finalScore="0.9943868275762621" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="356">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="potential" offset="464">
    <resource label="Electric field" uri="Electric_field" contextualScore="0.27376428764540783" percentageOfSecondRank="0.07620751255364996" support="3043" priorScore="2.5311741588728602E-5" finalScore="0.8409634334495861" types=""/>
  </surfaceForm>
  <surfaceForm name="CME" offset="368">
    <resource label="Continuing medical education" uri="Continuing_medical_education" contextualScore="0.981896288329898" percentageOfSecondRank="0.0027342720982225306" support="158" priorScore="1.3142475093720403E-6" finalScore="0.9943868275762621" types=""/>
  </surfaceForm>
  <surfaceForm name="refractory" offset="55">
    <resource label="Disease" uri="Disease" contextualScore="0.960670384210444" percentageOfSecondRank="0.11041419022299451" support="7304" priorScore="6.0754834230717615E-5" finalScore="0.9005609713333618" types=""/>
  </surfaceForm>
  <surfaceForm name="resorbed" offset="376">
    <resource label="Bone resorption" uri="Bone_resorption" contextualScore="0.9969578598341758" percentageOfSecondRank="7.235274370395373E-4" support="97" priorScore="8.068481544878982E-7" finalScore="0.9992769951349066" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="Need" offset="267">
    <resource label="Need" uri="Need" contextualScore="0.9956098373880771" percentageOfSecondRank="1.190371001746156E-4" support="251" priorScore="2.087823575015077E-6" finalScore="0.9998487808702816" types=""/>
  </surfaceForm>
  <surfaceForm name="case report" offset="22">
    <resource label="Case report" uri="Case_report" contextualScore="0.9999999918567255" percentageOfSecondRank="0.0" support="88" priorScore="7.319859545869592E-7" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="AND" offset="172">
    <resource label="Logical conjunction" uri="Logical_conjunction" contextualScore="0.605637734107441" percentageOfSecondRank="0.04412608481511602" support="780" priorScore="6.488057324748047E-6" finalScore="0.9573052167410165" types=""/>
  </surfaceForm>
  <surfaceForm name="reduce" offset="477">
    <resource label="Redox" uri="Redox" contextualScore="0.36642149564050613" percentageOfSecondRank="1.9706818860330464E-4" support="4934" priorScore="4.104112159013701E-5" finalScore="0.9995504581116257" types=""/>
  </surfaceForm>
  <surfaceForm name="injected" offset="221">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.9994740532843182" percentageOfSecondRank="3.1335758615976338E-6" support="361" priorScore="3.002806018248776E-6" finalScore="0.9999939361540234" types=""/>
  </surfaceForm>
  <surfaceForm name="After" offset="321">
    <resource label="Myst" uri="Myst" contextualScore="0.8148753883850143" percentageOfSecondRank="0.0844745284997539" support="606" priorScore="5.04072145999656E-6" finalScore="0.9124752706391652" types="Schema:CreativeWork, DBpedia:Work, DBpedia:Software, DBpedia:VideoGame"/>
  </surfaceForm>
  <surfaceForm name="CME" offset="105">
    <resource label="Continuing medical education" uri="Continuing_medical_education" contextualScore="0.981896288329898" percentageOfSecondRank="0.0027342720982225306" support="158" priorScore="1.3142475093720403E-6" finalScore="0.9943868275762621" types=""/>
  </surfaceForm>
  <surfaceForm name="injections" offset="342">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.999833227020243" percentageOfSecondRank="1.529003031318828E-5" support="361" priorScore="3.002806018248776E-6" finalScore="0.999984049935153" types=""/>
  </surfaceForm>
  <surfaceForm name="improve" offset="511">
    <resource label="Human enhancement" uri="Human_enhancement" contextualScore="0.8130219899308444" percentageOfSecondRank="0.05081518250769815" support="150" priorScore="1.2477033316823169E-6" finalScore="0.949884605579774" types=""/>
  </surfaceForm>
  <surfaceForm name="Ranibizumab" offset="444">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="defined" offset="289">
    <resource label="Well-defined" uri="Well-defined" contextualScore="0.6264405698620952" percentageOfSecondRank="0.2743900691503133" support="147" priorScore="1.2227492650486706E-6" finalScore="0.11177045145639267" types=""/>
    <resource label="Circle" uri="Circle" contextualScore="0.05833564065889779" percentageOfSecondRank="0.28465230040770206" support="3466" priorScore="2.8830264984072733E-5" finalScore="0.3926560624885377" types=""/>
    <resource label="Definition" uri="Definition" contextualScore="0.22948555063963422" percentageOfSecondRank="0.8612545924222125" support="682" priorScore="5.672891148048934E-6" finalScore="0.45591171988322593" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="150">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="205">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="OCT" offset="307">
    <resource label="Optical coherence tomography" uri="Optical_coherence_tomography" contextualScore="0.9999999982898089" percentageOfSecondRank="7.70424485855568E-10" support="75" priorScore="6.238516658411584E-7" finalScore="0.9999999992270432" types=""/>
  </surfaceForm>
  <surfaceForm name="CME" offset="500">
    <resource label="Continuing medical education" uri="Continuing_medical_education" contextualScore="0.981896288329898" percentageOfSecondRank="0.0027342720982225306" support="158" priorScore="1.3142475093720403E-6" finalScore="0.9943868275762621" types=""/>
  </surfaceForm>
  <surfaceForm name="patient" offset="42">
    <resource label="Patient" uri="Patient" contextualScore="0.9972043029873523" percentageOfSecondRank="2.7665873334954376E-6" support="2793" priorScore="2.323223603592474E-5" finalScore="0.9999971955006222" types=""/>
  </surfaceForm>
  <surfaceForm name="vision" offset="519">
    <resource label="Visual perception" uri="Visual_perception" contextualScore="0.003161327879701764" percentageOfSecondRank="1.427553250922954E-4" support="1964" priorScore="1.6336595622827136E-5" finalScore="0.21983160180520814" types=""/>
    <resource label="Visual acuity" uri="Visual_acuity" contextualScore="0.9968278846272045" percentageOfSecondRank="0.2817864883210682" support="457" priorScore="3.8013361505254586E-6" finalScore="0.7801353539518598" types=""/>
  </surfaceForm>
</annotation>